First Patient Enrolled in Revita® Wound Care Study

FlyerPhoto2.png

We’re excited to announce the commencement of our second level 1 clinical study for Revita!

This level 1 randomized controlled trial will assess the safety and efficacy of Revita as a wound covering for diabetic foot ulcers (DFUs). Diabetes impacts 30 million people across the United States, and as many as 25% of diabetic patients will develop a DFU within their lifetime.1-2 Without proper treatment, DFUs commonly result in amputation, leaving the patient with a 50% chance of survival. 3-4

As the first placental membrane allograft to capture the complete intact membrane in a shelf-stable format, Revita is uniquely capable of addressing DFUs. Since the product was launched, Revita has shown excellent effectiveness as a wound covering for a broad range of wound types including DFUs. This study will build on that experience and demonstrate broader, clinically validated outcomes.

We are thrilled to have this trial underway and are continuing to invest in high quality outcomes data for the complete portfolio of StimLabs products.

More information on this study can be found press release.

MKTG 19- 004 Rev 01

1. American Diabetes Association. Statistics About Diabetes. 2018 Mar.2. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA2005;293:217–228pmid:1564454.3. Alexiadou, Management of Diabetic Foot Ulcers. 2012 Apr 20.4. Armstrong DG, Wrobel J, Robbins JM. Guest editorial: are diabetes-related wounds and amputations worse than cancer? Int Wound J 2007;4:286–287pmid:18154621

What is Hyaluronic Acid?

By now, most of us have probably heard of hyaluronic acid (HA). Whether as a pain reliever for joints and tendons or a main ingredient in anti-aging serum, hyaluronic acid is widely-recognized as a key molecule found throughout the body.  But what is it that makes HA so unique? How does it work natively and where can it be sourced from? Watch this short video as StimLabs’ scientist, Annelise Roy, gives the lowdown on hyaluronic acid and its versatile functions.

MKTG 18-028 Rev 01